Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ovid Therapeutics Announces Pricing of $60 Million Private Placement (GlobeNewswire EN) +++ OVID THERAPEUTICS Aktie +12,75%

News zum Sektor Gesundheit aus Japan

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 102 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1551 Aktien zum Sektor Gesundheit bekannt.
 
17.03.26 - 20:15
KROS: Is the Discount Book Value a Value Trap? (Zacks)
 
Keros posts a 2025 revenue surge from Takeda licensing, but no product sales and volatile drivers leave investors weighing a discounted valuation against execution risk....
17.03.26 - 19:09
Nvidia attackiert mit dem ARM-Serverprozessor Vera auch AMD und Intel (Heise)
 
Server-Racks mit bis zu 22.528 CPU-Kernen: Nvidias Vera-CPU mit Olympus-Kernen kommt nicht nur im Gespann mit KI-Beschleunigern auf den Markt....
17.03.26 - 02:06
Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the ′Lab-in-the-Loop′ with NVIDIA (PR Newswire)
 
SHANGHAI, March 16, 2026 /PRNewswire/ -- Monday, March 16th at 1:30 PM PT, Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical in muscle wasting and lean mass imbalance, aiming to accelerate the......
16.03.26 - 21:36
What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment (Fool)
 
Viking Therapeutics develops clinical-stage therapies for metabolic and endocrine disorders, aiming to address unmet medical needs....
13.03.26 - 22:30
Bristol Myers Squibb to make immune cell cancer therapies in Japan (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
12.03.26 - 14:42
Eli Lilly to invest $125m in Japan plant to boost supply of new drugs (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
12.03.26 - 14:33
FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer (Business Wire)
 
HILLERØD, Denmark--(BUSINESS WIRE)--FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced the appointment of Christiane Bardroff as Chief Business Officer (CBO), effective June 1, 2026. Bardroff will lead commercial and sales, business insights and intelligence, strategic partnerships and global marketing, reporting directly to President and CEO Lars Petersen. Bardroff brings more than 18 years of experience and leadership across customer stewardship and biopharmaceutical operations, including process development and small-, mid-, and large-scale manufacturing, quality control, and quality assurance, as well as procurement, automation, and digitalization. Most recently, she was Chief Operating Officer at Rentschler Biopharma SE. Previously, she advanced through roles of increasing responsibility at Teva Biotech and Roche. As a people-first leader, she previously oversaw approximately 1,300 empl...
12.03.26 - 13:01
Bavarian Nordic and SII sign agreement for chikungunya vaccine production (PBR)
 
The contract covers a full technology transfer for the vaccine manufacturing process from Bavarian Nordic to SII, aiming to increase production capacity and future supply for endemic low- The post Bavarian Nordic and SII sign agreement for chikungunya vaccine production appeared first on Pharmaceutical Business review....
12.03.26 - 10:15
IPO: Legend Biotech Plans to List in HK as Early as This Yr, Raising at Least US$300M: Wire (AAStocks)
 
Legend Biotech (LEGN.US), a joint venture of GENSCRIPT BIO (01548.HK), planned to list in Hong Kong as early as this year, aiming to raise US$300-400 million, according to IFR.Legend Biotech was founded in 2014 and is the world's largest standalone cell therapy company, according to the Company's website.~AASTOCKS Financ......
11.03.26 - 19:30
WGS, Zevra Partner to Launch Genetic Testing for Niemann-Pick Type C (Zacks)
 
GeneDx launches Zevra-backed testing program to expand ExomeDx access for Niemann-Pick Type C, aiming to speed diagnosis and add data to its Infinity dataset....
11.03.26 - 15:45
Can Novo Nordisk′s Hims & Hers Deal Revive Its GLP-1 Momentum? (Zacks)
 
NVO partners with HIMS to expand access to Ozempic and Wegovy via telehealth, aiming to shift patients from compounded GLP-1s to FDA-approved drugs....
11.03.26 - 15:18
Olympus Launches Next-Generation Surgical Imaging Platform in U.S. (PR Newswire)
 
The VISERA ELITE™ III Platform Was Developed by the SONY Olympus Medical Joint Venture WESTBOROUGH, Mass., March 11, 2026 /PRNewswire/ -- Olympus Corporation proudly announces the U.S. launch of the VISERA ELITE™ III surgical imaging platform designed to enhance surgical visualization,......
11.03.26 - 13:03
Cognito Therapeutics Appoints Thomas Fagan as Executive Vice President, Alzheimer′s Portfolio (Business Wire)
 
Former Eisai and Eli Lilly Alzheimer's disease leader joins executive team to advance commercialization strategy for Spectris™CAMBRIDGE, Mass.--(BUSINESS WIRE)--#alzheimers--Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive therapies for neurodegenerative diseases, today announced the appointment of Thomas Fagan as Executive Vice President, Alzheimer's Portfolio, and a member of the company's Executive Leadership Team. Mr. Fagan brings more than 25 years of leadership experience across the pharmaceutical, medical device, and diagnostics industries, with deep expertise in Alzheimer's disease spanning diagnostics, therapeutics, and real-world clinical adoption. He has extensive experience building and aligning cross-functional teams, developing clinical-to-commercial pathways, and working with clinicians, health systems, and payers to accelerate adoption of innovative medical technologies. In his role at Cognito, Mr. Fagan will lead the company's Alzheimer's...
11.03.26 - 08:33
Latest data on long-term, real-world treatment with lecanemab will be presented at the AD/PD™ 2026 congress (PR Newswire)
 
STOCKHOLM, March 11, 2026 /PRNewswire/ -- BioArctic's AB (publ) (STOCKHOLM: BIOA B) partner Eisai announced today that they will present the latest findings on lecanemab at the 2026 International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™......
11.03.26 - 04:48
Trump′s drug cost push helps Astellas win higher price in Japan (Japan Times)
 
Japan, where medicine prices are among the lowest in the most developed nations, has become a critical reference point in U.S. plans to match drug prices with other countries....
11.03.26 - 04:18
Takeda Named Chair of Japan-South Korea Parliamentarians′ Union (Nippon)
 
Tokyo, March 11 (Jiji Press)--Former Japanese interior affairs minister Ryota Takeda was appointed chair of the Japan-South Korea parliamentarians' union, a suprapartisan group of Japanese lawmakers promoting ties between the two countries, on Tuesday. Takeda, a member of the ruling Liberal Democratic Party, succeeded former Prime Minister Yoshihide Suga, an LDP member who has retired from ......
11.03.26 - 00:33
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD™ 2026 Annual Meeting (PR Newswire)
 
TOKYO, March 10, 2026 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today the company will present the latest findings on lecanemab (generic name, U.S. brand name: LEQEMBI®), Eisai's anti-amyloid beta (Aβ) protofibril antibody for the treatment......
10.03.26 - 20:15
Stryker Introduces SmartHospital Platform to Advance Connected Care (Zacks)
 
SYK unveils SmartHospital Platform to link devices, data and care teams, aiming to boost hospital efficiency, clinical decisions and digital transformation....
09.03.26 - 18:46
UNH Deploys AI in Optum Rx to Tackle Pharmacy Fraud and Cost Leakage (Zacks)
 
UnitedHealth rolls out AI in Optum Rx to flag pharmacy fraud, billing anomalies and medication risks, aiming to curb cost leakage and improve compliance....
09.03.26 - 08:24
Daiichi Sankyo: FDA Grants Priority Review For ENHERTU (AFX)
 
LONDON (dpa-AFX) - Daiichi Sankyo (4568.T) and AstraZeneca's (AZN, AZN.L, ZEG.DE, AZN.ST) supplemental Biologics License Application for ENHERTU has been accepted and granted Priority Review in th......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: In Fährden ist das höchste Gut die Kühnheit. - In rebus dubiis plurimi est audacia. - Publilius Syrus
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!